These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 9453576)

  • 1. Partial inhibition of brain succinate dehydrogenase by 3-nitropropionic acid is sufficient to initiate striatal degeneration in rat.
    Brouillet E; Guyot MC; Mittoux V; Altairac S; Condé F; Palfi S; Hantraye P
    J Neurochem; 1998 Feb; 70(2):794-805. PubMed ID: 9453576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Major strain differences in response to chronic systemic administration of the mitochondrial toxin 3-nitropropionic acid in rats: implications for neuroprotection studies.
    Ouary S; Bizat N; Altairac S; Ménétrat H; Mittoux V; Condé F; Hantraye P; Brouillet E
    Neuroscience; 2000; 97(3):521-30. PubMed ID: 10828534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3-nitropropionic acid-induced mitochondrial permeability transition: comparative study of mitochondria from different tissues and brain regions.
    Mirandola SR; Melo DR; Saito A; Castilho RF
    J Neurosci Res; 2010 Feb; 88(3):630-9. PubMed ID: 19795369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic compromise with systemic 3-nitropropionic acid produces striatal apoptosis in Sprague-Dawley rats but not in BALB/c ByJ mice.
    Alexi T; Hughes PE; Knüsel B; Tobin AJ
    Exp Neurol; 1998 Sep; 153(1):74-93. PubMed ID: 9743569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Riluzole protects from motor deficits and striatal degeneration produced by systemic 3-nitropropionic acid intoxication in rats.
    Guyot MC; Palfi S; Stutzmann JM; Mazière M; Hantraye P; Brouillet E
    Neuroscience; 1997 Nov; 81(1):141-9. PubMed ID: 9300407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantifiable bradykinesia, gait abnormalities and Huntington's disease-like striatal lesions in rats chronically treated with 3-nitropropionic acid.
    Guyot MC; Hantraye P; Dolan R; Palfi S; Maziére M; Brouillet E
    Neuroscience; 1997 Jul; 79(1):45-56. PubMed ID: 9178864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serial 1H-NMR spectroscopy study of metabolic impairment in primates chronically treated with the succinate dehydrogenase inhibitor 3-nitropropionic acid.
    Dautry C; Condé F; Brouillet E; Mittoux V; Beal MF; Bloch G; Hantraye P
    Neurobiol Dis; 1999 Aug; 6(4):259-68. PubMed ID: 10448053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Participation of par-4 in the degeneration of striatal neurons induced by metabolic compromise with 3-nitropropionic acid.
    Duan W; Guo Z; Mattson MP
    Exp Neurol; 2000 Sep; 165(1):1-11. PubMed ID: 10964480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The adenosine A1 receptor agonist adenosine amine congener exerts a neuroprotective effect against the development of striatal lesions and motor impairments in the 3-nitropropionic acid model of neurotoxicity.
    Blum D; Gall D; Galas MC; d'Alcantara P; Bantubungi K; Schiffmann SN
    J Neurosci; 2002 Oct; 22(20):9122-33. PubMed ID: 12388620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The differential vulnerability of striatal projection neurons in 3-nitropropionic acid-treated rats does not match that typical of adult-onset Huntington's disease.
    Sun Z; Xie J; Reiner A
    Exp Neurol; 2002 Jul; 176(1):55-65. PubMed ID: 12093082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topological analysis of striatal lesions induced by 3-nitropropionic acid in the Lewis rat.
    Blum D; Gall D; Cuvelier L; Schiffmann SN
    Neuroreport; 2001 Jun; 12(8):1769-72. PubMed ID: 11409756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Astrocytes from cortex and striatum show differential responses to mitochondrial toxin and BDNF: implications for protection of striatal neurons expressing mutant huntingtin.
    Saba J; López Couselo F; Turati J; Carniglia L; Durand D; de Laurentiis A; Lasaga M; Caruso C
    J Neuroinflammation; 2020 Oct; 17(1):290. PubMed ID: 33023623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Death of cortical and striatal neurons induced by mitochondrial defect involves differential molecular mechanisms.
    Galas MC; Bizat N; Cuvelier L; Bantubungi K; Brouillet E; Schiffmann SN; Blum D
    Neurobiol Dis; 2004 Feb; 15(1):152-9. PubMed ID: 14751780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial toxin 3-nitropropionic acid produces startle reflex abnormalities and striatal damage in rats that model some features of Huntington's disease.
    Kodsi MH; Swerdlow NR
    Neurosci Lett; 1997 Aug; 231(2):103-7. PubMed ID: 9291151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atorvastatin attenuates mitochondrial toxin-induced striatal degeneration, with decreasing iNOS/c-Jun levels and activating ERK/Akt pathways.
    Lee ST; Chu K; Park JE; Hong NH; Im WS; Kang L; Han Z; Jung KH; Kim MW; Kim M
    J Neurochem; 2008 Mar; 104(5):1190-200. PubMed ID: 17976163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clorgyline and deprenyl attenuate striatal malonate and 3-nitropropionic acid lesions.
    Maragos WF; Tillman PA; Chesnut MD; Jakel RJ
    Brain Res; 1999 Jul; 834(1-2):168-72. PubMed ID: 10407109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Old mice present increased levels of succinate dehydrogenase activity and lower vulnerability to dyskinetic effects of 3-nitropropionic acid.
    Rosenstock TR; Abílio VC; Frussa-Filho R; Kiyomoto BH; Smaili SS
    Pharmacol Biochem Behav; 2009 Jan; 91(3):327-32. PubMed ID: 18765248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-methyl-D-aspartate receptor antagonists have variable affect in 3-nitropropionic acid toxicity.
    Nasr P; Carbery T; Geddes JW
    Neurochem Res; 2009 Mar; 34(3):490-8. PubMed ID: 18688711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 6-Hydroxydopamine injections into the nigrostriatal pathway attenuate striatal malonate and 3-nitropropionic acid lesions.
    Maragos WF; Jakel RJ; Pang Z; Geddes JW
    Exp Neurol; 1998 Dec; 154(2):637-44. PubMed ID: 9878198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Rho Kinase Inhibition in the Protective Effect of Fasudil and Simvastatin Against 3-Nitropropionic Acid-Induced Striatal Neurodegeneration and Mitochondrial Dysfunction in Rats.
    Ahmed LA; Darwish HA; Abdelsalam RM; Amin HA
    Mol Neurobiol; 2016 Aug; 53(6):3927-3938. PubMed ID: 26169112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.